VIR · Vir Biotechnology, Inc.

Summary

On March 4, 2026, the Board of Directors of Vir Biotechnology, Inc. appointed Marianne De Backer, M.Sc., Ph.D., MBA, its Chief Executive Officer and principal executive officer, to the additional position of President. There are no arrangements, understandings, or family relationships associated with the appointment.

Key takeaways

• Board appointed Marianne De Backer as President on March 4, 2026
• Dr. De Backer is Vir Biotechnology, Inc.'s Chief Executive Officer and principal executive officer
• Biographical information incorporated from proxy statement filed April 17, 2025
• No arrangements or understandings with any other person for the appointment
• No family relationship with any directors or executive officers